Thursday, March 28, 2024

TOPICS

Home Tags Dr. Yow-Pin Lim

Tag: Dr. Yow-Pin Lim

PROTHERA BIOLOGICS has entered into a licensing agreement with Takeda for the development of a plasma-derived therapy for treatment of acute inflammatory conditions.

ProThera enters agreement with Takeda for acute inflammatory condition treatment development

PROVIDENCE – ProThera Biologics Inc. has entered into a global licensing agreement with Takeda Pharmaceutical Co. Ltd. to develop a novel plasma-derived treatment of...
PROTHERA BIOLOGICS has been awarded a two-year $1.9 million Phase II grant from the National Institutes of Health to study the potential of a new test to assess prognosis of infants who have or might develop sepsis and necrotizing entercolitis.

ProThera receives $1.9M NIH grant for infant-assessment test research

PROVIDENCE – ProThera Biologics Inc. has been awarded a two-year $1.9 million Phase II grant from the National Institutes of Health to study the...
PROTHERA BIOLOGICS and Women & Infants Hospital were awarded $1.95 million to continue research into the medical potential of Inter-Alpha Inhibitor Proteins. Pictured is ProThera founder and CEO Yow-Pin Lim. / PBN FILE PHOTO/TRACY JENKINS

ProThera and WIH receive $1.95M in grant money

Updated at 3:08 p.m. PROVIDENCE - ProThera Biologics and Women & Infants Hospital were awarded a $1.95 million Phase II Small Business Innovation Research grant...
- Featured Event -

Latest News